Anti-Diabetic and Anti-Hyperlipidemic Effects of 2-[(Trimethylsilyl)-Oxy]-, Trimethylsilyl Ester Isolated from Pericampylus glaucus in Diabetic Rats

The purpose of the present study was to isolate and identify 2-[(trimethylsilyl)-oxy]-, trimethylsilyl ester compound from Pericampylus glaucus and to evaluate their effects on blood glucose and lipid profiles in diabetic rats. The isolation and identification of compound 2-[(trimethylsilyl)-oxy]-, trimethylsilyl ester was undertaken through column chromatography followed by GCMS and (HNMR)-H-1. The anti-hyperglycemic effect of isolated compound was carried out against STZ-induced diabetic rats. GC followed by MS and 1HNMR indicate the presence of compound 2-[(trimethylsilyl)-oxy]-, trimethylsilyl ester in sample. The weight was 234, retention time 2.99, and total area was 1015482. The compound significantly (P < 0.01) reduced blood glucose level in hyperglycemic rats as matched to control. The attenuation on blood glucose level with 2-[(trimethylsilyl)-oxy]-, trimethylsilyl ester were non-significant (P > 0.05) up to 4 h that became significant (P < 0.01) at 24 h as matched to diabetic group. A significant (P < 0.001) attenuation in levels of cholesterol, triglycerides, LDL and significant (P < 0.01) increased in HDL was noted in 2-[(trimethylsilyl)-oxy]-, trimethylsilyl ester treated group. The findings of this study indicate that isolated compound Pericampylus glaucus compound 2-[(trimethylsilyl)-oxy]-, trimethylsilyl ester has significant attenuation effect on blood glucose and lipid profiles.